Explorer
Bharat Biotech
Health
Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials
India
Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
India
Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval
Health
Govt Panel Recommends Regular Market Approval For Covishield And Covaxin
India
Receiving Reports That Children Being Administered Covid Jab Other Than Covaxin: Bharat Biotech
Health
Covaxin Now A Universal Covid-19 Vaccine For Adults, Children: Bharat Biotech
Health
Covaxin Booster Dose Shown To Neutralize Omicron, Delta Covid Variants: Bharat Biotech
Health
Covaxin Booster Jabs Trial Shows 'Long-Term Safety With No Adverse Events': Bharat Biotech
Health
No Paracetamol Or Painkillers Recommended After Being Vaccinated With Covaxin: Bharat Biotech
Health
DCGI Gives Nod To Bharat Biotech's Intranasal Covid Vaccine For Phase 3 'Booster Dose Study'
Health
‘False & Misleading’: Centre Dismisses Claims Of Expired COVID Vaccines Being Administered In India
Health
Covaxin Showed Good Immune Response In Children, Slightly Better Than Adults: NTAGI Chief
Advertisement
Advertisement
Top Headlines
Cities
EC Releases Assam Draft Rolls After Special Revision, 10.5 Lakh Voter Names Deleted
India
Supreme Court Takes Suo Moto Cognisance On Aravalli Case, Hearing On Monday
India
CWC Meet Flags G RAM G Bill, SIR, Bangladesh As Kharge Announces MGNREGA Agitation
World
7.0 Magnitude Earthquake Hits Taiwan’s Yilan, Damage Assessment Underway
